← Leaderboards
Y Jerold Gordon
University Of Pittsburgh At Pittsburgh
$2,355,107
Attributed
$2,355,107
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $438.1K · FY2005–06$500K$375K$250K$125K$0
'05
'06
Funding mix
By agency
NIH$2,355,107 · 1
By mechanism
R01$2,355,107 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- David A Lewis$38,866,023
- Parmjeet S Randhawa$5,320,349
- Eric Klann$20,406,593
- Bill J Yates$10,406,888
- Charleen T Chu$13,687,402
Others in their field
Top investigators on “Drug Screening /Evaluation”
- Fred M Gordin · Social And Scientific Systems, Inc.$68,001,399
- John C S Breitner · Johns Hopkins University$33,065,187
- Philip J Disaia · University Of California Irvine$21,551,991
- George R Painter · Chimerix, Inc.$19,230,662
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Stephen J Durako · Westat, Inc.$15,048,684
Research focus
Drug Screening /EvaluationTissue /Cell CultureLaboratory RabbitVirus ReplicationVirus DiseasesTopical Drug ApplicationCytosine AnalogAdenoviridaeAntiviral AgentsDrug ResistanceEye Disorder ChemotherapyEye InfectionsNonhuman Therapy EvaluationEye PharmacologyMolecular Pathology2'3'DideoxycytidineDisease /Disorder ModelDna Directed Dna PolymeraseHuman TissueImmunomodulatorsIn Situ HybridizationHost Organism InteractionGene TherapyNeuronal Transport
Grant awards (6)
Experimental Pathogenesis & Therapy of Ocular Adenovirus$433,537
R01 · FY2006 · EY · contact PI
Experimental Pathogenesis &Therapy of Ocular Adenovirus$438,106
R01 · FY2005 · EY
Experimental Pathogenesis &Therapy of Ocular Adenovirus$432,411
R01 · FY2004 · EY
Experimental Pathogenesis &Therapy of Ocular Adenovirus$428,320
R01 · FY2003 · EY
EXPERIMENTAL PATHOGENESIS &THERAPY OF OCULAR ADENOVIRUS$314,701
R01 · FY2001 · EY
EXPERIMENTAL PATHOGENESIS &THERAPY OF OCULAR ADENOVIRUS$308,032
R01 · FY2000 · EY